Thalidomide in Treating Patients With Myelofibrosis

Clinical trial NCT00015821 · COMPLETED

Trial details

NCT number: NCT00015821
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis

Start date: 2000-05-01
Primary completion: 2007-12-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.